This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: Yugiang Wang: Innovator in Antitumor Compounds
Introduction
Yugiang Wang is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor compounds. His innovative work has led to the creation of a unique patent that showcases his expertise and dedication to advancing cancer treatment.
Latest Patents
Yugiang Wang holds a patent for "Antitumor aldophosphamide glycoside and dideoxyuridine derivatives." This compound features a complex structure that includes various functional groups, which are designed to enhance its therapeutic efficacy against tumors. The specific structural components of the compound include variations of R and R1, which contribute to its potential effectiveness in cancer treatment.
Career Highlights
Wang is affiliated with the University of Texas System, where he continues to engage in research and development. His work is characterized by a commitment to innovation and a focus on creating solutions that address critical health challenges. His patent reflects his ability to merge scientific knowledge with practical applications in medicine.
Collaborations
Yugiang Wang collaborates with David Farquhar, a fellow researcher, to further explore the potential of his inventions. Their partnership exemplifies the importance of teamwork in scientific research and innovation.
Conclusion
Yugiang Wang's contributions to the field of antitumor compounds highlight his role as a leading inventor in medicinal chemistry. His patent serves as a testament to his innovative spirit and dedication to improving cancer treatment options.